One analyst reiterated his pessimistic view of the pharmaceutical titan's future.

Pfizer is making more changes to its layout in California by stepping away from a South San Francisco office site that used ...

Pfizer (NYSE:PFE) is accelerating its transformation with acquisitions of Seagen and Metsera to expand in oncology and anti ...

Although it's not generating tons of money from its COVID vaccine and pill anymore, the business is still doing well. There ...

Pfizer Inc. (NYSE:PFE) plays a significant role in global healthcare by supplying medicines and vaccines to healthcare ...

In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug ...

The news is the latest example of the biotech industry's struggles in the Bay Area.

Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on track, which should significantly boost the drugmaker's bottom line. Pfizer's ...

Learn how pharma company Pfizer makes money through prescription drugs, vaccines, oncology treatments, and global ...

One of the world’s largest biotech companies is closing its only office in the Bay Area. Pfizer is shutting down its office ...

They aren't just "pandemic stocks." ...

Pfizer Inc PFE shares are trading lower on Tuesday after the company and its COVID-19 vaccine partner paused an updated-shot ...